United States Pharmaceuticals

Bristol-Myers Squibb Co (BMY)

Track

Track

Bristol-Myers Squibb Co. experienced net selling activity totaling approximately $840,746 over the past 90 days. Executives, including the Chief Medical Officer, executed multiple sell transactions. This follows a positive earnings report where the company beat expectations by 28.3%. The stock price has risen 9% recently, currently trading near its 52-week high.
Ticker: BMY Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bristol-Myers Squibb Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Massacesi Cristian EVP,Chief Med Offr,Head of Dev Officer
Transaction date
Sale
Price
423.21
Quantity 10,987 +31.9%
Value US$3,260,910
Massacesi Cristian EVP,Chief Med Offr,Head of Dev Officer
Transaction date
Sale
Price
32.71
Quantity 40,364 +5.5%
Value US$1,176,178
Massacesi Cristian Officer Officer
Transaction date
Proposed sale
Price
22.88
Quantity 24,347
Value US$4,294,222
1.4
Holzer Phil M SVP and Controller Officer
Transaction date
Sale
Price
67.50
Quantity 500 -2.9%
Value US$33,750
1.4
Holzer Phil M Officer Officer
Transaction date
Proposed sale
Price
67.50
Quantity 500
Value US$33,750
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
62.05
Quantity 4,481 -2.7%
Value US$278,046
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
61.60
Quantity 25,519 -13.5%
Value US$1,571,970
1.2
Elkins David V Officer Officer
Transaction date
Proposed sale
Price
61.69
Quantity 30,000
Value US$1,850,645
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Planned sale
Price
47.33
Quantity 56,000 -25.1%
Value US$2,650,480
1.2
Elkins David V Officer Officer
Transaction date
Proposed sale
Price
47.30
Quantity 56,000
Value US$2,648,800
0.8
Short Bartie Wendy EVP, Corporate Affairs Officer
Transaction date
Sale
Price
44.23
Quantity 378 -6.9%
Value US$16,719
Hickey Benjamin President, RayzeBio Org. Officer
Transaction date
Sale
Price
38.01
Quantity 97 -100.0%
Value US$3,702
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
47.58
Quantity 4,250 +5.4%
Value US$202,215
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
55.05
Quantity 2,000 +1.9%
Value US$110,096
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
54.84
Quantity 1,823 +2.9%
Value US$100,000
1.4
Holzer Phil M SVP and Controller Officer
Transaction date
Sale
Price
55.62
Quantity 700 -5.6%
Value US$38,930
1.4
Holzer Phil M Officer Officer
Transaction date
Proposed sale
Price
55.62
Quantity 700
Value US$38,930
2.9
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Officer
Transaction date
Purchase
Price
54.68
Quantity 1,830 +3.0%
Value US$100,055
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Officer
Transaction date
Purchase
Price
49.78
Quantity 2,000 +2.5%
Value US$99,560
2.0
BOERNER CHRISTOPHER S. Chief Executive Officer Officer
Transaction date
Purchase
Price
48.86
Quantity 3,071 +4.0%
Value US$150,049
3.4
Samuels Theodore R. II Non-Executive Director
Transaction date
Purchase
Price
49.81
Quantity 8,500 +31.5%
Value US$423,385
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
61.25
Quantity 17,986 -39.2%
Value US$1,101,642
3.2
Powell Ann Officer Officer
Transaction date
Proposed sale
Price
61.25
Quantity 17,986
Value US$1,101,653
2.9
Plenge Robert M EVP, Chief Research Officer Officer
Transaction date
Sale
Price
61.14
Quantity 732 -10.0%
Value US$44,754
2.9
Plenge Robert M Officer Officer
Transaction date
Proposed sale
Price
61.14
Quantity 732
Value US$44,756
3.3
VESSEY RUPERT EVP & President, Research Officer
Transaction date
Sale
Price
67.06
Quantity 50,385 -51.3%
Value US$3,378,818
3.3
VESSEY RUPERT Officer Officer
Transaction date
Proposed sale
Price
67.06
Quantity 50,385
Value US$3,378,941
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
74.69
Quantity 11,183 -32.7%
Value US$835,258
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
74.65
Quantity 240,000 -50.4%
Value US$17,916,000
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
80.45
Quantity 16,250 -32.2%
Value US$1,307,312
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
78.88
Quantity 45,910 -44.6%
Value US$3,621,381
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Planned sale
Price
69.71
Quantity 25,000 -5.0%
Value US$1,742,750
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
71.84
Quantity 50,000 -9.1%
Value US$3,592,000
3.2
Powell Ann EVP, Chief Human Resources Officer
Transaction date
Sale
Price
70.75
Quantity 25,000 -33.1%
Value US$1,768,750
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
71.29
Quantity 103,951 -46.5%
Value US$7,410,667
1.2
Elkins David V EVP, Chief Financial Officer Officer
Transaction date
Sale
Price
71.35
Quantity 30,000 -23.0%
Value US$2,140,500
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
74.04
Quantity 30,000 -5.2%
Value US$2,221,200
2.8
LEUNG SANDRA EVP, General Counsel Officer
Transaction date
Sale
Price
74.89
Quantity 65,000 -17.4%
Value US$4,867,850
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Planned sale
Price
71.52
Quantity 25,000 -4.1%
Value US$1,788,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
69.23
Quantity 43,228 -46.2%
Value US$2,992,674
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
69.27
Quantity 31,331 -40.4%
Value US$2,170,298
1.6
Santiago Karen Murphy SVP & Controller Officer
Transaction date
Sale
Price
69.20
Quantity 6,577 -28.3%
Value US$455,096
2.0
BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer Officer
Transaction date
Sale
Price
69.20
Quantity 29,532 -41.3%
Value US$2,043,526
3.4
Caforio Giovanni Board Chair and CEO Executive Director
Transaction date
Sale
Price
67.00
Quantity 30,000 -6.2%
Value US$2,010,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.99
Quantity 13,100 -29.1%
Value US$812,069
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.99
Quantity 6,198 -12.1%
Value US$384,183
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
56.92
Quantity 17,353 -21.5%
Value US$987,733
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
57.47
Quantity 15,418 -16.0%
Value US$886,072
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
57.17
Quantity 18,363 -16.0%
Value US$1,049,813
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
68.08
Quantity 140,653 -75.0%
Value US$9,575,656
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
68.01
Quantity 17,740 -32.6%
Value US$1,206,497
2.4
Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply Officer
Transaction date
Sale
Price
65.25
Quantity 15,000 -31.9%
Value US$978,750
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
64.29
Quantity 30,546 -40.4%
Value US$1,963,802
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
64.21
Quantity 3,119 -16.1%
Value US$200,271
3.4
Caforio Giovanni Chairman and CEO Executive Director
Transaction date
Planned sale
Price
62.20
Quantity 25,000 -4.5%
Value US$1,555,000
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
63.50
Quantity 3 -0.0%
Value US$190
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
63.39
Quantity 900 -5.6%
Value US$57,051
1.7
von Autenried Paul EVP, Chief Information Officer Officer
Transaction date
Sale
Price
62.75
Quantity 20,000 -13.6%
Value US$1,255,000
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.34
Quantity 13,421 -26.1%
Value US$823,244
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.31
Quantity 47,012 -47.8%
Value US$2,882,306
3.3
VESSEY RUPERT EVP, Research & Early Dev. Officer
Transaction date
Sale
Price
61.25
Quantity 10,579 -18.7%
Value US$647,964
3.4
Caforio Giovanni Chairman and CEO Executive Director
Transaction date
Sale
Price
62.70
Quantity 39,840 -8.2%
Value US$2,497,968
2.3
Eid Joseph SVP,Head Glob. Medical Affairs Officer
Transaction date
Sale
Price
64.00
Quantity 5,327 -67.8%
Value US$340,928
2.8
LEUNG SANDRA EVP, General Counsel Officer
Transaction date
Sale
Price
63.24
Quantity 141,420 -24.6%
Value US$8,943,401
3.6
Paliwal Dinesh C Non-Executive Director
Transaction date
Purchase
Price
54.50
Quantity 9,174 +70.9%
Value US$499,983
3.0
Dubow Adam SVP,ChiefCompliance&EthicsOff. Officer
Transaction date
Sale
Price
61.01
Quantity 3,200 -16.6%
Value US$195,232
2.4
Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply Officer
Transaction date
Sale
Price
62.68
Quantity 25,000 -48.3%
Value US$1,567,000
2.3
Elicker John E EVP, Investor Relations Officer
Transaction date
Sale
Price
61.01
Quantity 15,805 -21.2%
Value US$964,263
3.3
VESSEY RUPERT Pres., Research & Early Dev. Officer
Transaction date
Sale
Price
60.59
Quantity 84,308 -63.6%
Value US$5,108,222
Dubow Adam Chief Compliance & Ethics Offi Officer
Transaction date
Sale
Price
58.81
Quantity 1,740 -9.9%
Value US$102,329
3.0
BONNEY MICHAEL W Non-Executive Director
Transaction date
Purchase
Price
58.90
Quantity 88 +1.2%
Value US$5,183
Elicker John E SVP, Public Affairs & IR Officer
Transaction date
Sale
Price
56.66
Quantity 15,000 -16.8%
Value US$849,900
Schmukler Louis S Pres., Global Mfg. & Supply Officer
Transaction date
Sale
Price
56.56
Quantity 25,000 -43.9%
Value US$1,414,000
BERTOLINI ROBERT J Non-Executive Director
Transaction date
Purchase
Price
44.72
Quantity 11,000 +2770.8%
Value US$491,920
1.6
Santiago Karen Murphy Controller
Transaction date
Sale
Price
47.56
Quantity 3,065 -50.0%
Value US$145,771
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-09 S Sale
Massacesi Cristian

EVP,Chief Med Offr,Head of Dev

Officer
10,987 +31.9%
423.21
US$3,260,910 		10,987 +31.9% 423.21 US$3,260,910
2026-09-10 2026-09-09 S Sale
Massacesi Cristian

EVP,Chief Med Offr,Head of Dev

Officer
40,364 +5.5%
32.71
US$1,176,178 		40,364 +5.5% 32.71 US$1,176,178
2026-09-09 2026-09-09 PrS Proposed sale
Massacesi Cristian

Officer

Officer
24,347
22.88
US$4,294,222 		24,347 22.88 US$4,294,222
2026-08-26 2026-08-25 S Sale
1.4
Holzer Phil M

SVP and Controller

Officer
500 -2.9%
67.50
US$33,750 		500 -2.9% 67.50 US$33,750
2026-08-25 2026-08-25 PrS Proposed sale
1.4
Holzer Phil M

Officer

Officer
500
67.50
US$33,750 		500 67.50 US$33,750
2026-04-02 2026-04-01 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
4,481 -2.7%
62.05
US$278,046 		4,481 -2.7% 62.05 US$278,046
2026-04-02 2026-04-01 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
25,519 -13.5%
61.60
US$1,571,970 		25,519 -13.5% 61.60 US$1,571,970
2026-04-01 2026-04-01 PrS Proposed sale
1.2
Elkins David V

Officer

Officer
30,000
61.69
US$1,850,645 		30,000 61.69 US$1,850,645
2025-09-03 2025-09-02 PlS Planned sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
56,000 -25.1%
47.33
US$2,650,480 		56,000 -25.1% 47.33 US$2,650,480
2025-09-02 2025-09-02 PrS Proposed sale
1.2
Elkins David V

Officer

Officer
56,000
47.30
US$2,648,800 		56,000 47.30 US$2,648,800
2025-08-05 2025-08-02 S Sale
0.8
Short Bartie Wendy

EVP, Corporate Affairs

Officer
378 -6.9%
44.23
US$16,719 		378 -6.9% 44.23 US$16,719
2025-05-13 2025-05-09 S Sale
Hickey Benjamin

President, RayzeBio Org.

Officer
97 -100.0%
38.01
US$3,702 		97 -100.0% 38.01 US$3,702
2025-04-29 2025-04-25 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
4,250 +5.4%
47.58
US$202,215 		4,250 +5.4% 47.58 US$202,215
2025-02-21 2025-02-20 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Executive Director
2,000 +1.9%
55.05
US$110,096 		2,000 +1.9% 55.05 US$110,096
2025-02-19 2025-02-14 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
1,823 +2.9%
54.84
US$100,000 		1,823 +2.9% 54.84 US$100,000
2024-11-05 2024-11-04 S Sale
1.4
Holzer Phil M

SVP and Controller

Officer
700 -5.6%
55.62
US$38,930 		700 -5.6% 55.62 US$38,930
2024-11-04 2024-11-04 PrS Proposed sale
1.4
Holzer Phil M

Officer

Officer
700
55.62
US$38,930 		700 55.62 US$38,930
2024-11-05 2024-11-01 B Purchase
2.9
Hirawat Samit

EVP,Chief Med.Offr.,Drug Dev.

Officer
1,830 +3.0%
54.68
US$100,055 		1,830 +3.0% 54.68 US$100,055
2023-12-07 2023-12-05 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Officer
2,000 +2.5%
49.78
US$99,560 		2,000 +2.5% 49.78 US$99,560
2023-11-30 2023-11-28 B Purchase
2.0
BOERNER CHRISTOPHER S.

Chief Executive Officer

Officer
3,071 +4.0%
48.86
US$150,049 		3,071 +4.0% 48.86 US$150,049
2023-11-21 2023-11-20 B Purchase
3.4
Samuels Theodore R. II
Non-Executive Director
8,500 +31.5%
49.81
US$423,385 		8,500 +31.5% 49.81 US$423,385
2023-08-28 2023-08-24 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
17,986 -39.2%
61.25
US$1,101,642 		17,986 -39.2% 61.25 US$1,101,642
2023-08-24 2023-08-24 PrS Proposed sale
3.2
Powell Ann

Officer

Officer
17,986
61.25
US$1,101,653 		17,986 61.25 US$1,101,653
2023-08-07 2023-08-03 S Sale
2.9
Plenge Robert M

EVP, Chief Research Officer

Officer
732 -10.0%
61.14
US$44,754 		732 -10.0% 61.14 US$44,754
2023-08-03 2023-08-03 PrS Proposed sale
2.9
Plenge Robert M

Officer

Officer
732
61.14
US$44,756 		732 61.14 US$44,756
2023-05-04 2023-05-03 S Sale
3.3
VESSEY RUPERT

EVP & President, Research

Officer
50,385 -51.3%
67.06
US$3,378,818 		50,385 -51.3% 67.06 US$3,378,818
2023-05-03 2023-05-03 PrS Proposed sale
3.3
VESSEY RUPERT

Officer

Officer
50,385
67.06
US$3,378,941 		50,385 67.06 US$3,378,941
2023-02-08 2023-02-06 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
11,183 -32.7%
74.69
US$835,258 		11,183 -32.7% 74.69 US$835,258
2023-02-08 2023-02-06 S Sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
240,000 -50.4%
74.65
US$17,916,000 		240,000 -50.4% 74.65 US$17,916,000
2022-11-14 2022-11-09 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
16,250 -32.2%
80.45
US$1,307,312 		16,250 -32.2% 80.45 US$1,307,312
2022-11-09 2022-11-07 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
45,910 -44.6%
78.88
US$3,621,381 		45,910 -44.6% 78.88 US$3,621,381
2022-09-22 2022-09-20 PlS Planned sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
25,000 -5.0%
69.71
US$1,742,750 		25,000 -5.0% 69.71 US$1,742,750
2022-09-16 2022-09-15 S Sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
50,000 -9.1%
71.84
US$3,592,000 		50,000 -9.1% 71.84 US$3,592,000
2022-09-15 2022-09-14 S Sale
3.2
Powell Ann

EVP, Chief Human Resources

Officer
25,000 -33.1%
70.75
US$1,768,750 		25,000 -33.1% 70.75 US$1,768,750
2022-09-15 2022-09-13 S Sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
103,951 -46.5%
71.29
US$7,410,667 		103,951 -46.5% 71.29 US$7,410,667
2022-09-15 2022-09-13 S Sale
1.2
Elkins David V

EVP, Chief Financial Officer

Officer
30,000 -23.0%
71.35
US$2,140,500 		30,000 -23.0% 71.35 US$2,140,500
2022-06-14 2022-06-13 S Sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
30,000 -5.2%
74.04
US$2,221,200 		30,000 -5.2% 74.04 US$2,221,200
2022-06-07 2022-06-06 S Sale
2.8
LEUNG SANDRA

EVP, General Counsel

Officer
65,000 -17.4%
74.89
US$4,867,850 		65,000 -17.4% 74.89 US$4,867,850
2022-03-23 2022-03-21 PlS Planned sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
25,000 -4.1%
71.52
US$1,788,000 		25,000 -4.1% 71.52 US$1,788,000
2022-03-18 2022-03-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
43,228 -46.2%
69.23
US$2,992,674 		43,228 -46.2% 69.23 US$2,992,674
2022-03-18 2022-03-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
31,331 -40.4%
69.27
US$2,170,298 		31,331 -40.4% 69.27 US$2,170,298
2022-03-16 2022-03-14 S Sale
1.6
Santiago Karen Murphy

SVP & Controller

Officer
6,577 -28.3%
69.20
US$455,096 		6,577 -28.3% 69.20 US$455,096
2022-03-16 2022-03-14 S Sale
2.0
BOERNER CHRISTOPHER S.

EVP, Chief Commercial Officer

Officer
29,532 -41.3%
69.20
US$2,043,526 		29,532 -41.3% 69.20 US$2,043,526
2022-02-28 2022-02-24 S Sale
3.4
Caforio Giovanni

Board Chair and CEO

Executive Director
30,000 -6.2%
67.00
US$2,010,000 		30,000 -6.2% 67.00 US$2,010,000
2021-12-17 2021-12-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
13,100 -29.1%
61.99
US$812,069 		13,100 -29.1% 61.99 US$812,069
2021-12-17 2021-12-16 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
6,198 -12.1%
61.99
US$384,183 		6,198 -12.1% 61.99 US$384,183
2021-11-24 2021-11-24 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
17,353 -21.5%
56.92
US$987,733 		17,353 -21.5% 56.92 US$987,733
2021-11-24 2021-11-23 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
15,418 -16.0%
57.47
US$886,072 		15,418 -16.0% 57.47 US$886,072
2021-11-24 2021-11-22 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
18,363 -16.0%
57.17
US$1,049,813 		18,363 -16.0% 57.17 US$1,049,813
2021-08-03 2021-07-30 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
140,653 -75.0%
68.08
US$9,575,656 		140,653 -75.0% 68.08 US$9,575,656
2021-08-03 2021-07-30 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
17,740 -32.6%
68.01
US$1,206,497 		17,740 -32.6% 68.01 US$1,206,497
2021-05-11 2021-05-10 S Sale
2.4
Schmukler Louis S

EVP,Pres.,Glob.Prod. & Supply

Officer
15,000 -31.9%
65.25
US$978,750 		15,000 -31.9% 65.25 US$978,750
2021-05-07 2021-05-05 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
30,546 -40.4%
64.29
US$1,963,802 		30,546 -40.4% 64.29 US$1,963,802
2021-05-07 2021-05-05 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
3,119 -16.1%
64.21
US$200,271 		3,119 -16.1% 64.21 US$200,271
2021-03-24 2021-03-22 PlS Planned sale
3.4
Caforio Giovanni

Chairman and CEO

Executive Director
25,000 -4.5%
62.20
US$1,555,000 		25,000 -4.5% 62.20 US$1,555,000
2020-11-30 2020-11-25 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
3 -0.0%
63.50
US$190 		3 -0.0% 63.50 US$190
2020-11-25 2020-11-24 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
900 -5.6%
63.39
US$57,051 		900 -5.6% 63.39 US$57,051
2020-11-25 2020-11-24 S Sale
1.7
von Autenried Paul

EVP, Chief Information Officer

Officer
20,000 -13.6%
62.75
US$1,255,000 		20,000 -13.6% 62.75 US$1,255,000
2020-11-25 2020-11-23 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
13,421 -26.1%
61.34
US$823,244 		13,421 -26.1% 61.34 US$823,244
2020-11-23 2020-11-19 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
47,012 -47.8%
61.31
US$2,882,306 		47,012 -47.8% 61.31 US$2,882,306
2020-11-23 2020-11-19 S Sale
3.3
VESSEY RUPERT

EVP, Research & Early Dev.

Officer
10,579 -18.7%
61.25
US$647,964 		10,579 -18.7% 61.25 US$647,964
2020-09-02 2020-08-31 S Sale
3.4
Caforio Giovanni

Chairman and CEO

Executive Director
39,840 -8.2%
62.70
US$2,497,968 		39,840 -8.2% 62.70 US$2,497,968
2020-08-19 2020-08-17 S Sale
2.3
Eid Joseph

SVP,Head Glob. Medical Affairs

Officer
5,327 -67.8%
64.00
US$340,928 		5,327 -67.8% 64.00 US$340,928
2020-08-17 2020-08-13 S Sale
2.8
LEUNG SANDRA

EVP, General Counsel

Officer
141,420 -24.6%
63.24
US$8,943,401 		141,420 -24.6% 63.24 US$8,943,401
2020-06-16 2020-06-15 B Purchase
3.6
Paliwal Dinesh C
Non-Executive Director
9,174 +70.9%
54.50
US$499,983 		9,174 +70.9% 54.50 US$499,983
2020-05-26 2020-05-22 S Sale
3.0
Dubow Adam

SVP,ChiefCompliance&EthicsOff.

Officer
3,200 -16.6%
61.01
US$195,232 		3,200 -16.6% 61.01 US$195,232
2020-05-21 2020-05-19 S Sale
2.4
Schmukler Louis S

EVP,Pres.,Glob.Prod. & Supply

Officer
25,000 -48.3%
62.68
US$1,567,000 		25,000 -48.3% 62.68 US$1,567,000
2020-03-06 2020-03-04 S Sale
2.3
Elicker John E

EVP, Investor Relations

Officer
15,805 -21.2%
61.01
US$964,263 		15,805 -21.2% 61.01 US$964,263
2020-03-04 2020-03-02 S Sale
3.3
VESSEY RUPERT

Pres., Research & Early Dev.

Officer
84,308 -63.6%
60.59
US$5,108,222 		84,308 -63.6% 60.59 US$5,108,222
2019-12-09 2019-12-05 S Sale Dubow Adam

Chief Compliance & Ethics Offi

Officer
1,740 -9.9%
58.81
US$102,329 		1,740 -9.9% 58.81 US$102,329
2020-06-09 2019-12-04 B Purchase
3.0
BONNEY MICHAEL W
Non-Executive Director
88 +1.2%
58.90
US$5,183 		88 +1.2% 58.90 US$5,183
2019-11-06 2019-11-05 S Sale Elicker John E

SVP, Public Affairs & IR

Officer
15,000 -16.8%
56.66
US$849,900 		15,000 -16.8% 56.66 US$849,900
2019-11-06 2019-11-05 S Sale Schmukler Louis S

Pres., Global Mfg. & Supply

Officer
25,000 -43.9%
56.56
US$1,414,000 		25,000 -43.9% 56.56 US$1,414,000
2019-08-01 2019-07-31 B Purchase BERTOLINI ROBERT J Non-Executive Director
11,000 +2770.8%
44.72
US$491,920 		11,000 +2770.8% 44.72 US$491,920
2019-05-20 2019-05-16 S Sale
1.6
Santiago Karen Murphy

Controller
3,065 -50.0%
47.56
US$145,771 		3,065 -50.0% 47.56 US$145,771
Explore more

More insider trading research around Bristol-Myers Squibb Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America
Insider trades in S&P 500